Tenderwize
Wróć do wyszukiwania

Open-house rebate agreement for multiple X-ray contrast agents

AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen·Erfurt, Germany·Deadline Mar 31, 2027 · 219 days left·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Oryginalny tytuł ogłoszenia

Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen im Rahmen eines sog. Open-House-Modells zu diversen Röntgenkontrastmitteln (ATC-Code nach WHO: V08)

46/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkOpen
Skąd ta ocena?

Szansa

46 / 100

Złożoność

58 / 100

Czynniki ryzyka

Submissions are only accepted by the monthly cut-off; late receipt is pushed to the next month, which can delay market...

Only the explicitly named contractor categories may participate.

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Mar 2027
  • Non-exclusive supply/rebate agreement for pharmaceutical products, specifically X-ray contrast agents under ATC code V08.
  • Open-house model with no individual negotiations and no delivery exclusivity.
Pokaż pełne podsumowanie

This is a German open-house supply arrangement for non-exclusive rebate agreements on multiple X-ray contrast agents (CPV 33600000) for AOK PLUS and associated health insurers. The notice states that participation is open to qualifying pharmaceutical companies, wholesalers, and public pharmacies, with no individual negotiations and no exclusivity. The procedure is unusual because the notice explicitly says it is not a public contract within the meaning of procurement law, although it is published in TED for transparency. Participation documents must be submitted electronically via DTVP after access approval, and the first submission deadline is 17 February 2025; afterwards, submissions are accepted by the 15th of each month until the agreement ends on 31 March 2027. No contract value is provided.

Ryzyka

Submissions are only accepted by the monthly cut-off; late receipt is pushed to the next month, which can delay market...

Only the explicitly named contractor categories may participate.

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Only pharmaceutical companies, wholesalers, or public pharmacies may act as contractors.

Eligibility

  • Required submissions include the completed declaration of no exclusion grounds under §§ 123, 124 GWB.

Administrative

  • Participation documents must be submitted fully and on time by the applicable monthly deadline.

Zamawiający

Lokalizacja

Erfurt, DEU

Profil zamawiającego

Otwórz profil

Identyfikator

DE256878834

Działalność

Health

Części (1)

LOT-0001

Open-house rebate agreement for multiple X-ray contrast agents

Open-house, non-exclusive rebate agreement for a broad set of contrast media under ATC V08. The lot covers multiple named substances including Amidotrizoesäure, Ioxitalaminsäure, Iohexol, Iopamidol, Iopromid, Ioversol, Iodixanol, Iomeprol, Iobitridol, Bariumsulfat, and several gadolinium-based agents. The notice states that purchase volumes are unknown and minimum volumes are not guaranteed. Performance/place of use is stated as Dresden, Germany, but the agreement applies nationally within Germany.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Dresden, Germany

Czas trwania

Mar 2025 - Mar 2027

Kategoria

Pharmaceutical products

Termin

Deadline Mar 31, 2027

Szczegóły zamówienia

Data publikacji
21 Jan 2025
Języki
German

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
43670-2025

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Belgium – Pharmaceutical products – Antimycotica

Aug 27

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3